tiprankstipranks
Avadel Pharmaceuticals (AVDL)
NASDAQ:AVDL

Avadel Pharmaceuticals (AVDL) Financial Statements

608 Followers

Avadel Pharmaceuticals Financial Overview

Avadel Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.024; its P/E ratio is -8.32; Avadel Pharmaceuticals is scheduled to report earnings on May 6, 2024, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 19.45M$ 7.01M$ 1.50M-$ 116.00K
Gross Profit$ 18.76M$ 6.90M$ 1.46M-$ -3.35M
EBIT$ -26.53M$ -34.21M$ -62.05M$ -28.11M$ -23.07M
EBITDA$ -26.55M$ -33.28M$ -60.86M$ -25.64M$ -20.58M
Net Income Common Stockholders$ -28.79M$ -36.27M$ -64.43M$ -30.78M$ -27.45M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 105.11M$ 153.18M$ 160.51M$ 100.92M$ 96.50M
Total Assets$ 164.70M$ 203.10M$ 200.98M$ 139.96M$ 132.78M
Total Debt$ 2.62M$ 24.03M$ 22.12M$ 115.16M$ 131.02M
Net Debt$ -102.49M$ -129.15M$ -138.39M$ 14.24M$ 34.52M
Total Liabilities$ 76.96M$ 92.95M$ 57.78M$ 178.91M$ 132.78M
Stockholders Equity$ 87.74M$ 110.15M$ 143.19M$ -38.17M$ -21.14M
Cash Flow-
Free Cash Flow$ -28.03M$ -25.10M$ -32.02M$ -30.23M$ -15.40M
Operating Cash Flow$ -28.03M$ -25.10M$ -32.02M$ -30.23M$ -15.40M
Investing Cash Flow$ 27.93M$ -3.31M$ -92.91M$ 5.07M$ 22.91M
Financing Cash Flow$ -21.11M$ 176.52M$ 91.54M$ 34.44M$ 6.62M
Currency in USD

Avadel Pharmaceuticals Earnings and Revenue History

Avadel Pharmaceuticals Debt to Assets

Avadel Pharmaceuticals Cash Flow

Avadel Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis